ALMS · Alumis Inc. Common Stock
View on chartInsiders & Stakes
| AyurMaya Capital Management Company, LP Director | ▲ Buy | Grant | 15,139,707 Shares held | 5/21/2025 | View profile |
| Foresite Capital Management V, LLC 10% Owner | ▲ Buy | Open Market | 4,202,670 Shares held | 7/1/2024 | View profile |
| Foresite Labs, LLC 10% Owner | ▼ Sell | Other | 680,486 Shares held | 4/1/2026 | View profile |
| Foresite Capital Management VI LLC 10% Owner | ▼ Sell | Other | 680,486 Shares held | 4/1/2026 | View profile |
| James B. Tananbaum Director | ▼ Sell | Other | 680,486 Shares held | 4/1/2026 | View profile |
| Roy C. Hardiman Chief Business & Legal Officer | ▼ Sell | Open Market | 207,746 Shares held | 8/3/2026 | View profile |
| Babler Martin President, CEO and Chairman | ▲ Buy | Open Market | 106,454 Shares held | 4/1/2025 | View profile |
| Jorn Drappa Chief Medical Officer | ▼ Sell | Open Market | 56,892 Shares held | 8/3/2026 | View profile |
| Mark Christopher Bradley Chief Development Officer | ▼ Sell | Open Market | 48,533 Shares held | 8/3/2026 | View profile |
| Richardson Derrick SVP, People and Culture | ▲ Buy | Grant | 42,800 Shares held | 7/29/2025 | View profile |
| Klein Sara General Counsel - Corp Secy | ▲ Buy | Grant | 33,796 Shares held | 7/1/2024 | View profile |
| David M. Goldstein Chief Scientific Officer | ▼ Sell | Open Market | 30,970 Shares held | 8/3/2026 | View profile |
| Zhengbin Yao | ▲ Buy | Grant | 27,082 Shares held | 6/30/2026 | View profile |
| John R. Schroer Chief Financial Officer | ▼ Sell | Open Market | 24,718 Shares held | 8/3/2026 | View profile |
| Colowick Alan | ▲ Buy | Open Market | 18,404 Shares held | 4/2/2025 | View profile |
| Sanam Pangali Chief Legal Officer | ▼ Sell | Open Market | 9,747 Shares held | 8/3/2026 | View profile |
| Lynn A. Tetrault Director | ▲ Buy | Grant | 3,553 Shares held | 6/30/2026 | View profile |
| Sapna Srivastava Director | ▲ Buy | Grant | 3,553 Shares held | 6/30/2026 | View profile |
| Patrick Machado | ▲ Buy | Grant | 3,553 Shares held | 6/30/2026 | View profile |
| Srinivas Akkaraju Director | ▲ Buy | Grant | 3,553 Shares held | 6/30/2026 | View profile |
Transaction History
| John R. Schroer | ▼ Sell | Open Market | 3,282 | $87K | 8/3/2026 |
| Sanam Pangali | ▼ Sell | Open Market | 1,364 | $36K | 8/3/2026 |
| Roy C. Hardiman | ▼ Sell | Open Market | 2,692 | $71K | 8/3/2026 |
| David M. Goldstein | ▼ Sell | Open Market | 2,596 | $68K | 8/3/2026 |
| Jorn Drappa | ▼ Sell | Open Market | 2,447 | $65K | 8/3/2026 |
| Mark Christopher Bradley | ▼ Sell | Open Market | 2,572 | $68K | 8/3/2026 |
| Sanam Pangali | ▲ Buy | Option Exercise | 5,000 | $25K | 7/6/2026 |
| Sanam Pangali | ▼ Sell | Open Market | 5,000 | $140K | 7/6/2026 |
| Lynn A. Tetrault | ▲ Buy | Grant | 3,553 | $0 | 6/30/2026 |
| Zhengbin Yao | ▲ Buy | Grant | 3,553 | $0 | 6/30/2026 |
| Sapna Srivastava | ▲ Buy | Grant | 3,553 | $0 | 6/30/2026 |
| Patrick Machado | ▲ Buy | Grant | 3,553 | $0 | 6/30/2026 |
| Srinivas Akkaraju | ▲ Buy | Grant | 3,553 | $0 | 6/30/2026 |
| Jorn Drappa | ▲ Buy | Option Exercise | 11,317 | $100K | 5/22/2026 |
| Jorn Drappa | ▲ Buy | Option Exercise | 15,535 | $79K | 5/22/2026 |
| Foresite Labs, LLC | ▼ Sell | Other | 1,123,337 | $0 | 4/1/2026 |
| Foresite Labs, LLC | ▼ Sell | Other | 1,123,337 | $0 | 4/1/2026 |
| Foresite Labs, LLC | ▼ Sell | Other | 1,176,470 | $0 | 4/1/2026 |
| Foresite Labs, LLC | ▼ Sell | Other | 680,486 | $0 | 4/1/2026 |
| Foresite Capital Management VI LLC | ▼ Sell | Other | 1,176,470 | $0 | 4/1/2026 |
| Foresite Capital Management VI LLC | ▼ Sell | Other | 1,123,337 | $0 | 4/1/2026 |
| Foresite Capital Management VI LLC | ▼ Sell | Other | 1,123,337 | $0 | 4/1/2026 |
| Foresite Capital Management VI LLC | ▼ Sell | Other | 680,486 | $0 | 4/1/2026 |
| James B. Tananbaum | ▼ Sell | Other | 1,176,470 | $0 | 4/1/2026 |
| James B. Tananbaum | ▼ Sell | Other | 1,123,337 | $0 | 4/1/2026 |
| James B. Tananbaum | ▼ Sell | Other | 1,123,337 | $0 | 4/1/2026 |
| James B. Tananbaum | ▼ Sell | Other | 680,486 | $0 | 4/1/2026 |
| Srinivas Akkaraju | ▲ Buy | Open Market | 588,235 | $10.0M | 1/9/2026 |
| Foresite Capital Management VI LLC | ▲ Buy | Open Market | 294,117 | $5.0M | 1/8/2026 |
| James B. Tananbaum | ▲ Buy | Open Market | 117,647 | $2.0M | 1/8/2026 |
| Foresite Labs, LLC | ▲ Buy | Open Market | 117,647 | $2.0M | 1/8/2026 |
| Foresite Labs, LLC | ▲ Buy | Open Market | 294,117 | $5.0M | 1/8/2026 |
| Foresite Capital Management VI LLC | ▲ Buy | Open Market | 117,647 | $2.0M | 1/8/2026 |
| James B. Tananbaum | ▲ Buy | Open Market | 294,117 | $5.0M | 1/8/2026 |
| Srinivas Akkaraju | ▲ Buy | Open Market | 64,969 | $581K | 12/5/2025 |
| Srinivas Akkaraju | ▲ Buy | Open Market | 70,028 | $701K | 12/5/2025 |
| Srinivas Akkaraju | ▲ Buy | Open Market | 51,380 | $551K | 12/5/2025 |
| Srinivas Akkaraju | ▲ Buy | Open Market | 66,027 | $540K | 12/4/2025 |
| Srinivas Akkaraju | ▲ Buy | Open Market | 100,000 | $775K | 12/3/2025 |
| Srinivas Akkaraju | ▲ Buy | Open Market | 96,000 | $725K | 12/2/2025 |
| Srinivas Akkaraju | ▲ Buy | Open Market | 86,350 | $644K | 12/1/2025 |
| Srinivas Akkaraju | ▲ Buy | Open Market | 38,702 | $296K | 11/28/2025 |
| Srinivas Akkaraju | ▲ Buy | Open Market | 48,537 | $371K | 11/26/2025 |
| Foresite Capital Management VI LLC | ▲ Buy | Open Market | 72,212 | $533K | 11/21/2025 |
| James B. Tananbaum | ▲ Buy | Open Market | 72,212 | $533K | 11/21/2025 |
| Foresite Labs, LLC | ▲ Buy | Open Market | 72,212 | $533K | 11/21/2025 |
| Srinivas Akkaraju | ▲ Buy | Open Market | 125,743 | $905K | 11/20/2025 |
| Foresite Labs, LLC | ▲ Buy | Open Market | 190,500 | $1.2M | 11/19/2025 |
| Foresite Capital Management VI LLC | ▲ Buy | Open Market | 190,500 | $1.2M | 11/19/2025 |
| James B. Tananbaum | ▲ Buy | Open Market | 190,500 | $1.2M | 11/19/2025 |
| Srinivas Akkaraju | ▲ Buy | Open Market | 137,772 | $904K | 11/19/2025 |
| Foresite Labs, LLC | ▲ Buy | Open Market | 117,374 | $727K | 11/18/2025 |
| Foresite Capital Management VI LLC | ▲ Buy | Open Market | 117,374 | $727K | 11/18/2025 |
| James B. Tananbaum | ▲ Buy | Open Market | 117,374 | $727K | 11/18/2025 |
| Srinivas Akkaraju | ▲ Buy | Open Market | 102,652 | $621K | 11/18/2025 |
| Foresite Labs, LLC | ▲ Buy | Open Market | 50,000 | $280K | 11/17/2025 |
| Foresite Labs, LLC | ▲ Buy | Open Market | 150,000 | $839K | 11/17/2025 |
| Foresite Capital Management VI LLC | ▲ Buy | Open Market | 50,000 | $280K | 11/17/2025 |
| Foresite Capital Management VI LLC | ▲ Buy | Open Market | 150,000 | $839K | 11/17/2025 |
| James B. Tananbaum | ▲ Buy | Open Market | 50,000 | $280K | 11/17/2025 |
| James B. Tananbaum | ▲ Buy | Open Market | 150,000 | $839K | 11/17/2025 |
| Srinivas Akkaraju | ▲ Buy | Open Market | 914 | $5K | 11/17/2025 |
| Srinivas Akkaraju | ▲ Buy | Open Market | 276,179 | $1.4M | 11/13/2025 |
| Sanam Pangali | ▲ Buy | Grant | 10,000 | $0 | 7/29/2025 |
| Richardson Derrick | ▲ Buy | Grant | 42,800 | $0 | 7/29/2025 |
| John R. Schroer | ▲ Buy | Grant | 28,000 | $0 | 7/29/2025 |
| Roy C. Hardiman | ▲ Buy | Grant | 28,000 | $0 | 7/29/2025 |
| David M. Goldstein | ▲ Buy | Grant | 27,000 | $0 | 7/29/2025 |
| Jorn Drappa | ▲ Buy | Grant | 25,450 | $0 | 7/29/2025 |
| Mark Christopher Bradley | ▲ Buy | Grant | 26,750 | $0 | 7/29/2025 |
| Srinivas Akkaraju | ▲ Buy | Grant | 1,214,582 | — | 5/21/2025 |
| Patrick Machado | ▲ Buy | Grant | 7,064 | — | 5/21/2025 |
| AyurMaya Capital Management Company, LP | ▲ Buy | Grant | 4,493,741 | — | 5/21/2025 |
| James B. Tananbaum | ▲ Buy | Open Market | 20,000 | $87K | 5/6/2025 |
| Foresite Labs, LLC | ▲ Buy | Open Market | 20,000 | $87K | 5/6/2025 |
| Foresite Capital Management VI LLC | ▲ Buy | Open Market | 20,000 | $87K | 5/6/2025 |
| Srinivas Akkaraju | ▲ Buy | Open Market | 138,368 | $634K | 5/5/2025 |
| Srinivas Akkaraju | ▲ Buy | Open Market | 22,002 | $116K | 5/5/2025 |
| James B. Tananbaum | ▲ Buy | Open Market | 25,000 | $116K | 5/2/2025 |
| Foresite Labs, LLC | ▲ Buy | Open Market | 25,000 | $116K | 5/2/2025 |
| Foresite Capital Management VI LLC | ▲ Buy | Open Market | 25,000 | $116K | 5/2/2025 |
| Srinivas Akkaraju | ▲ Buy | Open Market | 159,920 | $728K | 5/2/2025 |
| Colowick Alan | ▲ Buy | Open Market | 2,300 | $17K | 4/2/2025 |
| Colowick Alan | ▲ Buy | Open Market | 16,104 | $112K | 4/1/2025 |
| Babler Martin | ▲ Buy | Open Market | 15,650 | $101K | 4/1/2025 |
| Foresite Labs, LLC | ▼ Sell | Other | 1,944,577 | $0 | 7/1/2024 |
| Foresite Labs, LLC | ▼ Sell | Other | 1,122,994 | $0 | 7/1/2024 |
| Foresite Labs, LLC | ▼ Sell | Other | 560,076 | $0 | 7/1/2024 |
| Foresite Labs, LLC | ▼ Sell | Other | 622,344 | $0 | 7/1/2024 |
| Foresite Labs, LLC | ▼ Sell | Other | 1,022,398 | $0 | 7/1/2024 |
| Foresite Labs, LLC | ▲ Buy | Open Market | 312,500 | $5.0M | 7/1/2024 |
| Foresite Labs, LLC | ▼ Sell | Other | 194,459 | $0 | 7/1/2024 |
| Foresite Labs, LLC | ▼ Sell | Other | 481,283 | $0 | 7/1/2024 |
| Foresite Labs, LLC | ▼ Sell | Other | 560,076 | $0 | 7/1/2024 |
| Foresite Labs, LLC | ▼ Sell | Other | 311,172 | $0 | 7/1/2024 |
| Foresite Labs, LLC | ▼ Sell | Other | 681,598 | $0 | 7/1/2024 |
| Foresite Capital Management V, LLC | ▲ Buy | Open Market | 312,500 | $5.0M | 7/1/2024 |
| Foresite Capital Management V, LLC | ▼ Sell | Other | 194,459 | $0 | 7/1/2024 |
| Foresite Capital Management V, LLC | ▼ Sell | Other | 481,283 | $0 | 7/1/2024 |
| Foresite Capital Management V, LLC | ▼ Sell | Other | 560,076 | $0 | 7/1/2024 |
| Foresite Capital Management V, LLC | ▼ Sell | Other | 311,172 | $0 | 7/1/2024 |
| Foresite Capital Management V, LLC | ▼ Sell | Other | 681,598 | $0 | 7/1/2024 |
| Foresite Capital Management V, LLC | ▼ Sell | Other | 967,567 | $0 | 7/1/2024 |
| Foresite Capital Management V, LLC | ▼ Sell | Other | 311,172 | $0 | 7/1/2024 |
| Foresite Capital Management V, LLC | ▼ Sell | Other | 681,598 | $0 | 7/1/2024 |
| Foresite Capital Management V, LLC | ▼ Sell | Other | 311,172 | $0 | 7/1/2024 |
| Foresite Capital Management V, LLC | ▼ Sell | Other | 1,703,998 | $0 | 7/1/2024 |
| Foresite Capital Management V, LLC | ▲ Buy | Open Market | 2,187,500 | $35.0M | 7/1/2024 |
| James B. Tananbaum | ▼ Sell | Other | 1,122,994 | $0 | 7/1/2024 |
| James B. Tananbaum | ▼ Sell | Other | 560,076 | $0 | 7/1/2024 |
| James B. Tananbaum | ▼ Sell | Other | 622,344 | $0 | 7/1/2024 |
| James B. Tananbaum | ▼ Sell | Other | 1,022,398 | $0 | 7/1/2024 |
| James B. Tananbaum | ▲ Buy | Open Market | 312,500 | $5.0M | 7/1/2024 |
| James B. Tananbaum | ▼ Sell | Other | 194,459 | $0 | 7/1/2024 |
| James B. Tananbaum | ▼ Sell | Other | 481,283 | $0 | 7/1/2024 |
| James B. Tananbaum | ▼ Sell | Other | 560,076 | $0 | 7/1/2024 |
| James B. Tananbaum | ▼ Sell | Other | 311,172 | $0 | 7/1/2024 |
| James B. Tananbaum | ▼ Sell | Other | 681,598 | $0 | 7/1/2024 |
| James B. Tananbaum | ▼ Sell | Other | 967,567 | $0 | 7/1/2024 |
| James B. Tananbaum | ▼ Sell | Other | 311,172 | $0 | 7/1/2024 |
| James B. Tananbaum | ▼ Sell | Other | 681,598 | $0 | 7/1/2024 |
| James B. Tananbaum | ▼ Sell | Other | 311,172 | $0 | 7/1/2024 |
| James B. Tananbaum | ▼ Sell | Other | 1,703,998 | $0 | 7/1/2024 |
| James B. Tananbaum | ▲ Buy | Open Market | 2,187,500 | $35.0M | 7/1/2024 |
| AyurMaya Capital Management Company, LP | ▼ Sell | Other | 8,145,966 | — | 7/1/2024 |
| AyurMaya Capital Management Company, LP | ▲ Buy | Grant | 2,500,000 | $40.0M | 7/1/2024 |
| Zhengbin Yao | ▼ Sell | Other | 23,529 | — | 7/1/2024 |
| Zhengbin Yao | ▲ Buy | Grant | 23,529 | — | 7/1/2024 |
| Srinivas Akkaraju | ▼ Sell | Other | 1,703,998 | — | 7/1/2024 |
| Srinivas Akkaraju | ▼ Sell | Other | 1,703,998 | — | 7/1/2024 |
| Srinivas Akkaraju | ▲ Buy | Grant | 1,703,998 | — | 7/1/2024 |
| Klein Sara | ▼ Sell | Other | 33,796 | — | 7/1/2024 |
| Klein Sara | ▲ Buy | Grant | 33,796 | — | 7/1/2024 |
| Roy C. Hardiman | ▼ Sell | Other | 175,401 | — | 7/1/2024 |
| Roy C. Hardiman | ▲ Buy | Grant | 175,401 | — | 7/1/2024 |
| David M. Goldstein | ▼ Sell | Other | 213,903 | — | 7/1/2024 |
| David M. Goldstein | ▲ Buy | Grant | 213,903 | — | 7/1/2024 |
| David M. Goldstein | ▼ Sell | Other | 2,994 | — | 7/1/2024 |
| David M. Goldstein | ▲ Buy | Grant | 2,994 | — | 7/1/2024 |
| Mark Christopher Bradley | ▼ Sell | Other | 21,978 | — | 7/1/2024 |
| James B. Tananbaum | ▼ Sell | Other | 1,944,577 | $0 | 7/1/2024 |
| Foresite Capital Management V, LLC | ▼ Sell | Other | 622,344 | $0 | 7/1/2024 |
| Foresite Capital Management V, LLC | ▼ Sell | Other | 1,022,398 | $0 | 7/1/2024 |
| Foresite Labs, LLC | ▼ Sell | Other | 967,567 | $0 | 7/1/2024 |
| Foresite Labs, LLC | ▼ Sell | Other | 311,172 | $0 | 7/1/2024 |
| Foresite Labs, LLC | ▼ Sell | Other | 681,598 | $0 | 7/1/2024 |
| Foresite Labs, LLC | ▼ Sell | Other | 311,172 | $0 | 7/1/2024 |
| Foresite Labs, LLC | ▼ Sell | Other | 1,703,998 | $0 | 7/1/2024 |
| Foresite Labs, LLC | ▲ Buy | Open Market | 2,187,500 | $35.0M | 7/1/2024 |
| Foresite Capital Management V, LLC | ▼ Sell | Other | 1,944,577 | $0 | 7/1/2024 |
| Foresite Capital Management V, LLC | ▼ Sell | Other | 1,122,994 | $0 | 7/1/2024 |
| Foresite Capital Management V, LLC | ▼ Sell | Other | 560,076 | $0 | 7/1/2024 |
| Roy C. Hardiman | ▲ Buy | Grant | 6,417 | — | 7/1/2024 |
| Mark Christopher Bradley | ▲ Buy | Grant | 21,978 | — | 7/1/2024 |
| Mark Christopher Bradley | ▼ Sell | Other | 20,026 | — | 7/1/2024 |
| Mark Christopher Bradley | ▲ Buy | Grant | 20,026 | — | 7/1/2024 |
| Mark Christopher Bradley | ▼ Sell | Other | 20,026 | — | 7/1/2024 |
| Mark Christopher Bradley | ▲ Buy | Grant | 20,026 | — | 7/1/2024 |
| Babler Martin | ▼ Sell | Other | 90,804 | — | 7/1/2024 |
| Babler Martin | ▲ Buy | Grant | 90,804 | — | 7/1/2024 |
| Roy C. Hardiman | ▼ Sell | Other | 6,417 | — | 7/1/2024 |